Other languages Immuron Limited

Equities

Market Closed - Australian S.E. Other stock markets 11:10:01 30/04/2024 am IST			5-day change	1st Jan Change
0.1 ^AUD	0.00%		0.00%	+29.87%

10/04	Immuron Limited Provides Sales Results for the Quarter and Year to Date Ended March 2024	CI
10/04	Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	MT

Immuron's Global Sales Climb 51% in March Quarter; Shares Surge 18%	10/04
Sector Update: Health Care Stocks Gain Late Afternoon	08/03
Sector Update: Health Care	08/03
Top Midday Gainers	08/03
Top Premarket Gainers	07/03
Immuron Moving Anti-Diarrhea Drug to Phase Three Trials	07/03
Immuron Limited Announces Positive Results Support Travelan Progress to Phase 3 Clinical Trials in the US	07/03
Immuron Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
Immuron Posts Record Travelan Sales in Fiscal H1	16/01
Immuron Limited Clinical Trials Update	22/12
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study	04/12
Immuron Limited Announces Travelan® Clinical Study Cohort 2 Commences	18/23/18
Immuron Reports Big Jump in Fiscal Q1 Travelan Sales	11/23/11
Immuron Limited Reports Earnings Results for the Full Year Ended June 30, 2023	30/23/30
Immuron Limited Receives TGA GMP Clearance	09/23/09
Immuron Secures Clearance for Packaging of Immunotherapy Product; Shares Surge 27%	09/23/09
Immuron Says First Patients Enrolled in Travelan Trial	25/23/25
Immuron Limited Announces First Patients Enrolled in Travelan® Clinical Study	25/23/25
Immuron Enrolls First Patients in Travelan Clinical Study	25/23/25
Immuron Posts 136% Jump in Fiscal 2023 Sales of Travelan, Protectyn Supplements	05/23/05

No results for this search